Form 4 for CAPR CAPRICOR THERAPEUTICS, INC.
Accepted 2026-04-01 20:00:15 ET · period of report 2026-03-31 · accession 0001593086-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-04-01 20:00 | 2026-03-31 | CAPR | Krasney Karen | EVP, GC | M - OptEx | $3.61 | +25.0K | 55.5K | +82% | +$90.3K |
| DT | 2026-04-01 20:00 | 2026-03-31 | CAPR | Krasney Karen | EVP, GC | S - Sale+OE | $30.12 | -25.0K | 30.5K | -45% | -$752.9K |
| DMT | 2026-04-01 20:00 | 2026-03-31 | CAPR | Krasney Karen | EVP, GC | M - OptEx | $0.00 | -25.0K | 81.3K | -24% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-31 | M | A | 693 | $1.39 | 31,240 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-31 | M | A | 21,488 | $3.74 | 52,728 | D | — | — | |
| 3 | Common | Common Stock | 2026-03-31 | M | A | 2,819 | $3.18 | 55,547 | D | — | — | |
| 4 | Common | Common Stock | 2026-03-31 | S | D | 25,000 | $30.12 | 30,547 | D | — | — | (F1) Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. (F2) The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.31, inclusive. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-03-31 | M | D | 693 | $0.00 | 2,807 | D | $1.39 · — to 2028-01-02 | 693 Common Stock | (F3) This option was granted on January 2, 2018 and was previously reported as covering 35,000 shares at an exercise price of $1.57 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020. (F3) This option was granted on January 2, 2018 and was previously reported as covering 35,000 shares at an exercise price of $1.57 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020. (F4) Shares vested 1/48th on the first day of each month commencing February 1, 2018. |
| 6 | Derivative | Stock Option (Right to Buy) | 2026-03-31 | M | D | 21,488 | $0.00 | 74,205 | D | $3.74 · — to 2031-01-04 | 21,488 Common Stock | (F5) Shares vested 1/48th on the first day of each month commencing February 1, 2021. |
| 7 | Derivative | Stock Option (Right to Buy) | 2026-03-31 | M | D | 2,819 | $0.00 | 81,261 | D | $3.18 · — to 2032-01-03 | 2,819 Common Stock | (F6) Shares vested 1/48th on the first day of each month commencing February 1, 2022. |